36results about How to "Treatment fit" patented technology

The invention belongs to the field of traditional Chinese medicine formulae and particularly relates to a medicine for treating infantile malnutrition. The medicine for treating infantile malnutrition is prepared from the following raw medicinal materials by weight: 50-70g of rhizoma atractylodis, 50-70g of bighead atractylodes rhizome, 50-70g of trigone, 50-70g of poria, 8-12g of dragon blood, 8-12g of cinnabar, 8-12g of realgar, 10-14g of vermilion and 25-35g of massa medicata fermentata fujianensis. The traditional Chinese medicine provided by the invention ha the advantages of being simple in formula, low in price, short in treatment course, good in curative effect, high in cure rate and the like. By adopting the medicinal components, the medicine provided by the invention has the functions of removing food retention and eliminating stagnancy, transporting spleen and stomach and quickly recovering the functions of internal organs. The medicine for treating infantile malnutrition is effective within 5-8 days commonly and is capable of treating both symptoms and root causes. In addition, the raw materials are low in price, so that the medicine is very suitable for treating the general public.

The invention discloses a Chinese patent medicine for treating the infantile malnutrition of infants, which belongs to the field of traditional Chinese medicines. The medicine selects barley, tangerine peel, charred hawthorn, chicken's gizzard-membrane and stir-fried semen raphani to be combined, and the combination of these medicines enables the effect of each medicine to generate a synergistic action, thereby treating the infantile malnutrition of the infants effectively.

The invention relates to a medicine for treating coronary heat disease, angina and arrhythmia, and particularly relates to a medicine for treating coronary heat disease, angina and arrhythmia, prepared from animals, plants and Chinese herbal medicines, and a preparation method thereof, belonging to the field of medicines. The medicine is prepared from the following raw materials in parts by weight: 0.5-1.5 parts of charcoal grilled toad, 100-150 parts of salvia miltiorrhiza, 150-200 parts of ligusticum wallichii, 30-50 parts of leech, 80-100 parts of trogopterus dung, 10-30 parts of sandalwood, 80-100 parts of rhizome acori graminei, 150-200 parts of lily, 100-150 parts of polygala tenuifolia, 150-200 parts of radix ophiopogonis, 80-100 parts of allium macrostemon and 80-100 parts of cassia twig. The preparation method comprises the steps of drying and grinding the raw materials to powder of 100-200 meshes, and sieving; then, mixing according to the proportion, carrying out sterilization treatment, and blending to prepare the medicine. The medicine is prepared from natural animals, plants and Chinese herbal medicines, and the drug property is moderate. The medicine has no toxic or side effect or adverse reaction, and is suitable for patients suffering from coronary heat disease, angina, myocardial infarction and arrhythmia for long-time use.

The invention relates to a traditional Chinese medicine composition for preventing and/or treating pneumonia. Pholidota chinensis is taken as the monarch drug and then is compounded with reed root, welsh onion stalk, loquat leaf, ephedra stem, fritillaria cirrhosa, honeysuckle flower, kelp, perilla, dandelion, and haw. The traditional Chinese medicine has a prominent and quick effect on treating pneumonia, and is suitable for clinical treatment of various pneumonias. The relapse is difficult.

The invention discloses an externally-applied medicine for treating the infantile malnutrition of infants, which belongs to the field of traditional Chinese medicines. The medicine selects cape jasmine of Mount Huang, almond, white pepper, clove, egg white, onion and wheat to be combined, and the combination of these medicines enables the effect of each medicine to generate a synergistic action, thereby treating the infantile malnutrition of the infants effectively.

The invention discloses an oral drug for treating gastric ulcer, which is prepared by the following 12 Chinese herbal medicines: ginseng, codonopsis pilosula, bupleurum, malaytea scurfpea fruit, bighead atractylodes rhizome, bitter orange, yam, coix seed, dwarf lilyturf tuber, dried orange peel, fructus amomi and costustoot. The raw materials are prepared into oral power, granules, capsules and tablets by the processing steps of charging materials, distilling, being extracted by water, decorating in mixture, filtering, drying and preparing. The oral drug is a traditional Chinese medicine preparation for treating gastric ulcer and is suitable for treating various digestive tract diseases such as gastric ulcer. The oral drug has the effects of tonifying spleen and stomach by warm-natured medicaments, diminishing inflammation and detoxifying, relieving pain, dissipating swelling and increasing food appetite.

The present invention discloses oral supplement fluid salt powder and a preparation method thereof. The oral supplement fluid salt powder is composed of sodium chloride, potassium chloride, sodium citrate and anhydrous glucose. The preparation method is composed of a pulverizing step, a mixing step and a sub-packaging step; the pulverizing step is respectively pulverizing sodium chloride, potassium chloride and sodium citrate; and the mixing step is putting anhydrous glucose within half of a prescription amount into a mixer, adding the prescription amount of the sodium chloride, potassium chloride and sodium citrate, starting the mixer to start mixing, and taking out the drug powder after mixing to conduct sieving and dispersing; and adding the sieved powder to the mixer, adding the remaining anhydrous glucose, and starting the machine again to complete mixing. The preparation method reduces content of sodium and glucose, thus lowers osmotic pressure, and is more suitable for dehydration prevention of infants and young children and fluid supplement of mild to moderate dehydration without circulation failure.

The invention relates to the field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for treating insomnia caused by internally attacking phlegm-heat, the traditional Chinese medicine composition comprises the following components: 20-40g of concha margaritiferallsta, 10-20g of prepared pinellia tuber, 10-20g poria with hostwood, 6-20g of rheum officinale, 6-20g of coptis chinensis, 6-20g of chlorite schist, 6-20g of orange peel, 6-20g of Chinese mahonia, 5-15g of moutan bark, 5-15g of bamboo shavings, 4-13g of dried orange peel, 4-13g of jujube kernel, 4-13g of arisaema cum bile, 3-10 of agilawood, 3-10 of lophatherum gracile and 3-10 of lily, the traditional Chinese medicine composition has excellent effect on treatment of insomnia caused by internally attacking phlegm-heat, the cure rate is higher than 88%, and 97.78% to the highest, the average cure rate is 94.08%, the total efficiency is 100%, and the traditional Chinese medicine composition is very suitable for the treatment of insomnia caused by internally attacking phlegm-heat.

The invention relates to a cantilever gyration mechanism of a gamma-ray source. One end of a transverse arm (8) is fixed on the upper end of a stand column (6), and the other end of the transverse arm (8) is fixedly connected with a radioactive source body (10). The length of the part of the transverse arm (8) hung out of the stand column (6) is 500-1500mm, and the distance of the gyration radius from the gamma-ray source body (10) to the nearest point of an isocenter line (12) is 320-550mm. In the invention, the transverse arm (8) of the gamma-ray source gyrates around the horizontal isocenter line (12) through a gyration shaft (5), wherein, the gyration speed ranges from 0.8 to 6 turns per minute. The gyration radius of the radioactive source is increased in the invention to ensure that the infection focus of a patient can be totally focused on a target spot during radiotherapy, thus the gyration mechanism has the characteristics of simple structure and convenient use, can be applied to gamma-ray or other radioactive energy beam therapy apparatuses, and is particularly suitable for treating whole-body focus infection by the gamma-ray source.

The invention relates to a medicine for treating a malignant tumor, particularly relates to a medicine for method for treating the malignant tumor of the digestive system and a preparation method of the medicine, and belongs to the field of medicines. The medicine is prepared from the materials of animals, plants and Chinese herbal medicines. The medicine comprises the following materials in parts by weight: 90-110 parts of fresh fetus cervi, 1-2 parts of pternopetalum davidii, 30-40 parts of charcoal grilled toad, 30-40 parts of charcoal grilled tree frog, 15-20 parts of charcoal grilled mole, 140-160 parts of mulberry, 20-30 parts of centipede, 90-110 parts of tribulus terrestris, 140-160 parts of dried body of ground beetle, 90-110 parts of bighead atractylodes rhizome, and 90-100 parts of gizzard pepsin. The preparation method comprises the following steps: firstly, the materials are dried and grinded into fine powder of 100-200 meshes, and screened; then the processed materials are blended according to the proportions, sterilized, and uniformly mixed to form the medicine. The medicine uses the purely natural animal and plant materials, the property of the medicine is mild, no toxic or side effect and adverse reaction are produced, and the medicine is suitable for treating the malignant tumor of the digestive system.

The invention discloses a medicine composition for treating pancreatitis and an application thereof. The composition is prepared from, by weight, 16-23 parts of pheretima aspergillum, 18-25 parts of rhizoma anemarrhenae, 18-25 parts of holothuria leucospilota, 18-25 parts of cortex albiziae, 11-20 parts of snakegourd fruits, 11-20 parts of bay leaves, 4-8 parts of compounds of glauber-salt and liquorice, 22-30 parts of oysters and 9-18 parts of Chinese lives. The selected medicinal materials are proper in compatibility, the remarkable curative effect is achieved for treating pancreatitis, the treatment course is short, effect taking is quick, and no relapse is caused after pancreatitis is cured. The medicine composition is safe, free of toxic and side effects, easy to take and low in cost, and can achieve the purpose of treating both symptoms and root causes.

The invention relates to the field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for the treatment of insomnia caused by fire excess from yin deficiency, the traditional Chinese medicine composition comprises the following components: 20-50g of lily, 20-40g of tuber fleeceflower stem, 10-30g of semen sesami nigrum, 10-25g of liquorice, 10-25 g of cortex cinnamomi, 8-15 g of angelica, 8-15 g of cortex moutan, 5-15 g of radix rehmanniae recen, 5-15 g of pulp of dogwood fruit, 5-15 g of rhizoma ligustici wallichii, 5-15 g of radix achyranthis bidentatae, 5-15 g of dogwood, 5-15 g of poria cocos, 3-10 of Chinese-date, 2-10 g of Chinese yam and 1-8 g of eucommia bark, the traditional Chinese medicine composition has excellent effect on treatment of insomnia caused by fire excess from yin deficiency, the cure rate is higher than 90%, and 98.3% to the highest, the average cure rate is 95.5%, the total efficiency is 100%, and the traditional Chinese medicine composition is very suitable for the treatment of insomnia caused by fire excess from yin deficiency.

The invention discloses a traditional Chinese medicine enema liquid for treating children's wet heat invasion type acute glomerulonephritis. The enema liquid is prepared from the following traditional Chinese herbals and western medicines in parts by weight: 5 parts of cyathula root, 5 parts of rhizoma atractylodis, 5 parts of phellodendron, 5 parts of coix seed, 7 parts of poria cocos, 5 parts of oriental waterplantain rhizome, 5 parts of plantain seed, 6 parts of bighead atractylodes rhizome, 5 parts of ligusticum wallichii, 5 parts of red sage root, 5 parts of tree peony bark, 5 parts of red peony root, 7 parts of Chinese yam, 2 parts of amber, 6 parts of cornus officinalis, 5 parts of circium japonicum, 5 parts of Japanese eupatorium, 5 parts of cooked rhubarb, 7 parts of semen cuscutae, 7 parts of wolfberry, 7 parts of cherokee rose-hip, 6 parts of raspberry, 8 parts of gorgon fruit, 5 parts of mantis egg-case, 5 parts of radix astragali, 5 parts of licorice, 7 parts of radix codonopsis, 10 parts of oldenlandia diffusa, 5 parts of earthworm, 5 parts of pyrrosia lingua, 10 parts of garlic, 6 parts of kendir leaf, 8 parts of cordate houttuynia, 5 parts of radical lobelia, 5 parts of morinda officinalis, 5 parts of hippocampus, 5 parts of cynomorium songaricum, 5 parts of eucommia, 5 parts of polygonatum rhizome, 10 parts of barbat skullcap, 5 parts of lygodium japonicum, 5 parts of imperata rhizome, and furazolidone tablet. The enema liquid can treat both the root and symptoms of acute glomerulonephritis; the components can generate a synergetic effect, the treatment time is shortened, and the cure rate is improved.

The invention belongs to the technical field of dialysis, and particularly discloses an adjustable sequential treatment peritoneal dialysis machine and a dialysis method.The adjustable sequential treatment peritoneal dialysis machine comprises a plurality of fluid infusion channels, a heating module, a main controller, an electromagnetic valve driving module, a solution metering module and an electromagnetic valve set module; inlets of the plurality of fluid infusion channels are respectively connected with dialysis bags with different dialysis solution concentrations or different dialysis solution types, and outlets of the plurality of fluid infusion channels are all connected with a heating bag; the main controller is respectively connected with the electromagnetic valve driving module and the solution metering module; the solution metering module is used for respectively metering the flow of the dialysis solution flowing into the heating bag from the plurality of fluid infusion channels and sending metering data to the main controller. The concentration Cn and the use amount Vn of the dialysate for treatment are set, the main controller calculates and selects the fluid infusion channel, the fluid infusion channel is controlled to be opened and closed according to flow data fed back by the solution metering module, accurate control over the concentration and the use amount of the dialysate is achieved, and the conditions of operation errors and low configuration efficiency caused by manual operation are avoided.